The Effect of Long-Term Aggressive Lipid Lowering on Ischemic and Atherosclerotic Burden in Patients with Chronic Kidney Disease

American Journal of Kidney Diseases

Volumn 43, Issue 1, 2004, Pages 45-52

  Fathi, Robert ^a   Isbel, Nicole ^a   Short, Leanne ^a   Haluska, Brian ^a   Johnson, David ^a   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Carotid intima media thickness (IMT); Chronic kidney disease (CKD); Lipid lowering; Renal disease

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DOBUTAMINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART MUSCLE ISCHEMIA; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; STRESS ECHOCARDIOGRAPHY;

EID: 0347359339     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.09.012     Document Type: Article

References (31)

1. US Renal Data System: Patient mortality and survival. Am J Kidney Dis 32:S69-S80, 1998 (suppl 1)
2. Herzog CA, Ma JZ, Collins AJ: Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207-2211, 2002
3. Harris K, Thomas M, Short C, Moore R: Assessment of the efficiency of treatment of dyslipidaemia in renal outpatients. J Nephrol 15:263-269, 2002
4. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37:484-489, 2001
5. Ozsoy RC, Kastelein JJ, Arisz L, Koopman MG: Atorvastatin and the dyslipidemia of early renal failure. Atherosclerosis 166:187-194, 2003
6. National Kidney Foundation: K/DOQI: Treating Dyslipidemias. Am J Kidney Dis 41:S39-S58, 2003 (suppl 3)
7. Fathi R, Haluska B, Short L, Marwick TH: A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention. Am J Med 114:445-453, 2003
8. Schwartz GG, Olsson AG, Ezekowitz MD, et al: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. JAMA 285:1711-1718, 2001
9. Medical Research Council/British Heart Foundation: Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22, 2002
10. Seliger SL, Weiss NS, Gillen DL, et al: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61:297-304, 2002
11. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
12. Cosio FG, Pesavento TE, Pelletier RP, et al: Patient survival after renal transplantation. III: The effects of statins. Am J Kidney Dis 40:638-643, 2002
13. Holdaas H, Fellstrom B, Jardine AG, et al: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 361:2024-2031, 2003
14. Stenvinkel P: Inflammation in end-stage renal failure: Could it be treated? Nephrol Dial Transplant 17:S33-S38, 2002 (suppl 8)
15. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 74:1399-1406, 1986
16. Bots ML, Hofman A, Grobbee DE: Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. Stroke 28:2442-2447, 1997
17. Hodis HN, Mack WJ, LaBree L, et al: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262-269, 1998
18. Grundy SM, Balady GJ, Criqui MH, et al: Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97:1876-1887, 1998
19. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367, 1989
20. Fathi R, Marwick TH: Noninvasive tests of vascular function and structure: Why and how to perform them. Am Heart J 141:694-703, 2001
21. Byington RP, Furberg CD, Crouse JR III, Espeland MA, Bond MG: Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 76:54C-59C, 1995
22. Mercuri M, Bond MG, Sirtori CR, et al: Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Aiherosclerosis Italian Ultrasound Study. Am J Med 101:627-634, 1996
23. Baldassarre D, Veglia F, Gobbi C, et al: Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: The carotid atherosclerosis Italian ultrasound study. Atherosclerosis 151:575-583, 2000
24. Salonen R, Nyssonen K, Porkkala-Sarataho E, Salonen JT: The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am J Cardiol 76:34C-39C, 1995
25. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial. Lancet 357:577-581, 2001
26. Shoji T, Emoto M, Tabata T, et al: Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 61:2187-2192, 2002
27. Konings CJ, Dammers R, Rensma PL, et al: Arterial wall properties in patients with renal failure. Am J Kidney Dis 39:1206-1212, 2002
28. Kawagishi T, Nishizawa Y, Konishi T, et al: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820-826, 1995
29. Hojs R: Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 24:S691-S695, 2000 (suppl 3)
30. Nishizawa Y, Shoji T, Maekawa K, et al: Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41:S76-S79, 2003 (suppl 1)
31. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12:2458-2464, 2001